NHS reference costs: a history and cautionary note
AbstractHistorically, the NHS did not routinely collect cost data, unlike many countries with private insurance markets. In 1998, for the first time the government mandated NHS trusts to submit estimates of their costs of service, known as reference costs. These have informed a wide range of health economic evaluations and important functions in the health service, such as setting prices.Reference costs are collected by progressively disaggregating budgets top-down into disease and treatment groups. Despite ongoing improvements to methods and guidance, these submissions continued to suffer a lack of accuracy and comparabil...
Source: Health Economics Review - November 22, 2023 Category: International Medicine & Public Health Source Type: research
Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model
ConclusionsPalbociclib and Ribociclib showed significant efficacy in combination with Letrozole, as evidenced by improvements in PFS. However, in the first-line treatment of MBC in Iran, these strategies were not cost-effective compared to Letrozole monotherapy. (Source: Health Economics Review)
Source: Health Economics Review - November 9, 2023 Category: International Medicine & Public Health Source Type: research
Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model
Palbociclib and Ribociclib are cyclin-dependent kinase 4/6 oral molecular inhibitors that have the potential to improve overall survival (OS), progression-free survival (PFS), and quality of life in patients w... (Source: Health Economics Review)
Source: Health Economics Review - November 9, 2023 Category: Health Management Authors: Ali Darvishi, Rajabali Daroudi and Ali Akbar Fazaeli Tags: Research Source Type: research
Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model
ConclusionsPalbociclib and Ribociclib showed significant efficacy in combination with Letrozole, as evidenced by improvements in PFS. However, in the first-line treatment of MBC in Iran, these strategies were not cost-effective compared to Letrozole monotherapy. (Source: Health Economics Review)
Source: Health Economics Review - November 9, 2023 Category: International Medicine & Public Health Source Type: research
Supply-side factors influencing demand for facility-based delivery in Tanzania: a multilevel analysis
ConclusionsPolicy responses should aim for strategies to improve demand like health education to raise awareness towards care seeking among less educated groups and those with higher parity, reduce financial barriers to access (including time costs to reach and access care), and policy interventions to enhance interpersonal quality in service provision. (Source: Health Economics Review)
Source: Health Economics Review - November 6, 2023 Category: International Medicine & Public Health Source Type: research
Supply-side factors influencing demand for facility-based delivery in Tanzania: a multilevel analysis
Improving access to facility-based delivery care has the potential to reduce maternal and newborn deaths across settings. Yet, the access to a health facility for childbirth remains low especially in low-incom... (Source: Health Economics Review)
Source: Health Economics Review - November 6, 2023 Category: Health Management Authors: Peter Binyaruka, Anna Foss, Abdullah Alibrahim, Nicholaus Mziray, Rachel Cassidy and Josephine Borghi Tags: Research Source Type: research
Supply-side factors influencing demand for facility-based delivery in Tanzania: a multilevel analysis
ConclusionsPolicy responses should aim for strategies to improve demand like health education to raise awareness towards care seeking among less educated groups and those with higher parity, reduce financial barriers to access (including time costs to reach and access care), and policy interventions to enhance interpersonal quality in service provision. (Source: Health Economics Review)
Source: Health Economics Review - November 6, 2023 Category: International Medicine & Public Health Source Type: research
Forecasting emergency department arrivals using INGARCH models
ConclusionOur results suggest that INGARCH modelling is a useful model for short-term and tactical emergency department planning, e.g., to assign rotas or locate staff for unexpected surges in patient arrivals. (Source: Health Economics Review)
Source: Health Economics Review - October 28, 2023 Category: International Medicine & Public Health Source Type: research
Forecasting emergency department arrivals using INGARCH models
Forecasting patient arrivals to hospital emergency departments is critical to dealing with surges and to efficient planning, management and functioning of hospital emerency departments. (Source: Health Economics Review)
Source: Health Economics Review - October 28, 2023 Category: Health Management Authors: Juan C. Reboredo, Jose Ramon Barba-Queiruga, Javier Ojea-Ferreiro and Francisco Reyes-Santias Tags: Research Source Type: research
Forecasting emergency department arrivals using INGARCH models
ConclusionOur results suggest that INGARCH modelling is a useful model for short-term and tactical emergency department planning, e.g., to assign rotas or locate staff for unexpected surges in patient arrivals. (Source: Health Economics Review)
Source: Health Economics Review - October 28, 2023 Category: International Medicine & Public Health Source Type: research
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model
ConclusionsIn Brazil, pioglitazone presented a higher probability of being cost-effective both in primary and secondary prevention, followed by SGLT2i and GLP-1A. Our findings support the use of cost-effectiveness models to build optimized and hierarchical therapeutic strategy in the management of T2DM.Trial registrationCRD42020194415. (Source: Health Economics Review)
Source: Health Economics Review - October 25, 2023 Category: International Medicine & Public Health Source Type: research
Correction: Economic burden of chronic migraine in OECD countries: a systematic review
(Source: Health Economics Review)
Source: Health Economics Review - October 25, 2023 Category: International Medicine & Public Health Source Type: research
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model
ConclusionsIn Brazil, pioglitazone presented a higher probability of being cost-effective both in primary and secondary prevention, followed by SGLT2i and GLP-1A. Our findings support the use of cost-effectiveness models to build optimized and hierarchical therapeutic strategy in the management of T2DM.Trial registrationCRD42020194415. (Source: Health Economics Review)
Source: Health Economics Review - October 25, 2023 Category: International Medicine & Public Health Source Type: research
Correction: Economic burden of chronic migraine in OECD countries: a systematic review
(Source: Health Economics Review)
Source: Health Economics Review - October 25, 2023 Category: Health Management Authors: Alyaa Eltrafi, Sunil Shrestha, Ali Ahmed, Hema Mistry, Vibhu Paudyal and Saval Khanal Tags: Correction Source Type: research
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model
The escalating prevalence of type 2 diabetes (T2DM) poses an unparalleled economic catastrophe to developing countries. Cardiovascular diseases remain the primary source of costs among individuals with T2DM, i... (Source: Health Economics Review)
Source: Health Economics Review - October 25, 2023 Category: Health Management Authors: Ana Claudia Cavalcante Nogueira, Joaquim Barreto, Filipe A. Moura, Beatriz Luchiari, Abr ão Abuhab, Isabella Bonilha, Wilson Nadruz, J. Michael Gaziano, Thomas Gaziano, Luiz Sergio F. de Carvalho and Andrei C. Sposito Tags: Research Source Type: research
